| scholarly article | Q13442814 |
| P50 | author | Christoph E. Hagemeyer | Q41769331 |
| Karlheinz Peter | Q47504540 | ||
| Xiaowei Wang | Q58312038 | ||
| P2093 | author name string | Jan David Hohmann | |
| Jathushan Palasubramaniam | |||
| Bock Lim | |||
| Yung Chih Chen | |||
| Yannik Gkanatsas | |||
| P2860 | cites work | Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial | Q28185728 |
| Novel single-chain antibody-targeted microbubbles for molecular ultrasound imaging of thrombosis: validation of a unique noninvasive method for rapid and sensitive detection of thrombi and monitoring of success or failure of thrombolysis in mice | Q28267720 | ||
| Successful microbubble sonothrombolysis without tissue-type plasminogen activator in a rabbit model of acute ischemic stroke | Q30465321 | ||
| Molecular Imaging of Activated von Willebrand Factor to Detect High-Risk Atherosclerotic Phenotype | Q30473382 | ||
| Sonothrombolysis of intra-catheter aged venous thrombi using microbubble enhancement and guided three-dimensional ultrasound pulses | Q30474318 | ||
| Antiangiogenic cancer therapy: monitoring with molecular US and a clinically translatable contrast agent (BR55). | Q30474689 | ||
| A contrast agent recognizing activated platelets reveals murine cerebral malaria pathology undetectable by conventional MRI | Q30481283 | ||
| Conformation-specific blockade of the integrin GPIIb/IIIa: a novel antiplatelet strategy that selectively targets activated platelets | Q33246904 | ||
| Subtractive single-chain antibody (scFv) phage-display: tailoring phage-display for high specificity against function-specific conformations of cell membrane molecules | Q33310276 | ||
| Triggers, targets and treatments for thrombosis | Q33765444 | ||
| Sustained thromboprophylaxis mediated by an RBC-targeted pro-urokinase zymogen activated at the site of clot formation | Q33944248 | ||
| Visualization of activated platelets by targeted magnetic resonance imaging utilizing conformation-specific antibodies against glycoprotein IIb/IIIa | Q34038326 | ||
| Coronary and microvascular thrombolysis with guided diagnostic ultrasound and microbubbles in acute ST segment elevation myocardial infarction | Q35608036 | ||
| Molecular imaging of coronary atherosclerosis and myocardial infarction: considerations for the bench and perspectives for the clinic | Q36095916 | ||
| Molecular imaging of thrombus: technology in evolution | Q36135602 | ||
| Prophylactic thrombolysis by thrombin-activated latent prourokinase targeted to PECAM-1 in the pulmonary vasculature | Q36445835 | ||
| Molecular imaging of inflammation and platelet adhesion in advanced atherosclerosis effects of antioxidant therapy with NADPH oxidase inhibition. | Q36617730 | ||
| Delayed targeting of CD39 to activated platelet GPIIb/IIIa via a single-chain antibody: breaking the link between antithrombotic potency and bleeding? | Q36779378 | ||
| Platelets, inflammation and atherosclerosis | Q36884400 | ||
| Translating molecular discoveries into new therapies for atherosclerosis | Q37089723 | ||
| Advanced drug delivery systems for antithrombotic agents. | Q37132620 | ||
| Diagnostic ultrasound combined with glycoprotein IIb/IIIa-targeted microbubbles improves microvascular recovery after acute coronary thrombotic occlusions | Q37364671 | ||
| How to make better use of thrombolytic therapy in acute ischemic stroke | Q37889116 | ||
| Atherosclerosis: current pathogenesis and therapeutic options | Q37953777 | ||
| Properties, characteristics and applications of microbubbles for sonothrombolysis. | Q38176653 | ||
| Cardiovascular drug delivery with ultrasound and microbubbles | Q38187761 | ||
| The tissue-type plasminogen activator story | Q39824852 | ||
| The GP IIb/IIIa inhibitor abciximab (c7E3) inhibits the binding of various ligands to the leukocyte integrin Mac-1 (CD11b/CD18, alphaMbeta2). | Q40690209 | ||
| Therapeutic Use of Avidin Is Not Hampered by Antiavidin Antibodies in Humans | Q42477444 | ||
| Thrombus-targeted perfluorocarbon-containing liposomal bubbles for enhancement of ultrasonic thrombolysis: in vitro and in vivo study. | Q44077486 | ||
| Particle generation, functionalization and sortase A-mediated modification with targeting of single-chain antibodies for diagnostic and therapeutic use. | Q48245916 | ||
| Transcranial ultrasound in clinical sonothrombolysis (TUCSON) trial | Q48488852 | ||
| Enzymatic single-chain antibody tagging: a universal approach to targeted molecular imaging and cell homing in cardiovascular disease. | Q50518016 | ||
| Dual-contrast molecular imaging allows noninvasive characterization of myocardial ischemia/reperfusion injury after coronary vessel occlusion in mice by magnetic resonance imaging. | Q51073149 | ||
| GPIIb/IIIa inhibitors: from bench to bedside and back to bench again. | Q51625353 | ||
| In vivo clot lysis of human thrombus with intravenous abciximab immunobubbles and ultrasound. | Q51732892 | ||
| Towards effective and safe thrombolysis and thromboprophylaxis: preclinical testing of a novel antibody-targeted recombinant plasminogen activator directed against activated platelets. | Q51750193 | ||
| Dissolution of thrombotic arterial occlusion by high intensity, low frequency ultrasound and dodecafluoropentane emulsion: an in vitro and in vivo study. | Q52526631 | ||
| Noninvasive in vivo clot dissolution without a thrombolytic drug: recanalization of thrombosed iliofemoral arteries by transcutaneous ultrasound combined with intravenous infusion of microbubbles. | Q52528869 | ||
| High-frequency ultrasound-guided disruption of glycoprotein VI-targeted microbubbles targets atheroprogressison in mice. | Q52654271 | ||
| In vivo thrombolysis with targeted microbubbles loading tissue plasminogen activator in a rabbit femoral artery thrombus model. | Q53589220 | ||
| Single-chain antibodies as diagnostic tools and therapeutic agents | Q57716695 | ||
| Ultrasound-Enhanced Systemic Thrombolysis for Acute Ischemic Stroke | Q57757056 | ||
| Thrombolytic enhancement with perfluorocarbon-exposed sonicated dextrose albumin microbubbles | Q71728132 | ||
| Albumin Microbubble Echo-Contrast Material as an Enhancer for Ultrasound Accelerated Thrombolysis | Q71993125 | ||
| Flow cytometric monitoring of glycoprotein IIb/IIIa blockade and platelet function in patients with acute myocardial infarction receiving reteplase, abciximab, and ticlopidine: continuous platelet inhibition by the combination of abciximab and ticlo | Q72998287 | ||
| Construction and functional evaluation of a single-chain antibody fusion protein with fibrin targeting and thrombin inhibition after activation by factor Xa | Q73544076 | ||
| Targeting ligand-induced binding sites on GPIIb/IIIa via single-chain antibody allows effective anticoagulation without bleeding time prolongation | Q79830051 | ||
| Magnetic resonance imaging contrast agent targeted toward activated platelets allows in vivo detection of thrombosis and monitoring of thrombolysis | Q81508480 | ||
| Efficacy and safety of once weekly subcutaneous idrabiotaparinux in the treatment of patients with symptomatic deep venous thrombosis | Q85193701 | ||
| Single-chain antibody conjugated to a cage amine chelator and labeled with positron-emitting copper-64 for diagnostic imaging of activated platelets | Q88226626 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | thrombosis | Q261327 |
| microbubble | Q6839290 | ||
| P304 | page(s) | 726-738 | |
| P577 | publication date | 2016-03-20 | |
| P1433 | published in | Theranostics | Q21051383 |
| P1476 | title | Thrombus-Targeted Theranostic Microbubbles: A New Technology towards Concurrent Rapid Ultrasound Diagnosis and Bleeding-free Fibrinolytic Treatment of Thrombosis | |
| P478 | volume | 6 |
| Q33588134 | A Unique Recombinant Fluoroprobe Targeting Activated Platelets Allows In Vivo Detection of Arterial Thrombosis and Pulmonary Embolism Using a Novel Three-Dimensional Fluorescence Emission Computed Tomography (FLECT) Technology |
| Q64238207 | Activated platelets in the tumor microenvironment for targeting of antibody-drug conjugates to tumors and metastases |
| Q47177380 | An unmet clinical need: The history of thrombus imaging |
| Q57026911 | Application of Ultrasound in Food Science and Technology: A Perspective |
| Q50655505 | Click-Chemistry-Mediated Rapid Microbubble Capture for Acute Thrombus Ultrasound Molecular Imaging. |
| Q45071762 | Dual targeting improves capture of ultrasound microbubbles towards activated platelets but yields no additional benefit for imaging of arterial thrombosis. |
| Q52662484 | Dual-Targeted Theranostic Delivery of miRs Arrests Abdominal Aortic Aneurysm Development. |
| Q90669000 | EWVDV-Mediated Platelet-Targeting Nanoparticles for the Multimodal Imaging of Thrombi at Different Blood Flow Velocities |
| Q30362955 | Fe3O4-based PLGA nanoparticles as MR contrast agents for the detection of thrombosis. |
| Q28073354 | From basic mechanisms to clinical applications in heart protection, new players in cardiovascular diseases and cardiac theranostics: meeting report from the third international symposium on "New frontiers in cardiovascular research" |
| Q88636954 | Gas‑filled ultrasound microbubbles enhance the immunoactivity of the HSP70‑MAGEA1 fusion protein against MAGEA1‑expressing tumours |
| Q64892310 | Microbubbles used for contrast enhanced ultrasound and theragnosis: a review of principles to applications. |
| Q98238182 | Molecular magnetic resonance imaging of activated platelets allows noninvasive detection of early myocarditis in mice |
| Q92424208 | Monoclonal antibody-based molecular imaging strategies and theranostic opportunities |
| Q55416268 | Multimodal Molecular Imaging: Current Status and Future Directions. |
| Q92887400 | New experimental animal model of intracardiac thrombus created with epicardial echocardiographic guidance |
| Q93082867 | Platelet bio-nanobubbles as microvascular recanalization nanoformulation for acute ischemic stroke lesion theranostics |
| Q50673192 | Platelet microparticle-inspired clot-responsive nanomedicine for targeted fibrinolysis. |
| Q41240124 | Platelet-Targeted Delivery of Peripheral Blood Mononuclear Cells to the Ischemic Heart Restores Cardiac Function after Ischemia-Reperfusion Injury |
| Q90353535 | Polydopamine-modified dual-ligand nanoparticles as highly effective and targeted magnetic resonance/photoacoustic dual-modality thrombus imaging agents |
| Q89910045 | Recent strategies on targeted delivery of thrombolytics |
| Q92279499 | Surface Modification with Lactadherin Augments the Attachment of Sonazoid Microbubbles to Glycoprotein IIb/IIIa |
| Q41430279 | Targeting Activated Platelets: A Unique and Potentially Universal Approach for Cancer Imaging |
| Q38847912 | The effects of particle size, shape, density and flow characteristics on particle margination to vascular walls in cardiovascular diseases |
| Q38670007 | The potential roles of bacteria to improve radiation treatment outcome. |
| Q47966546 | Therapeutic application of contrast ultrasound in ST elevation myocardial infarction: Role in coronary thrombosis and microvascular obstruction. |
| Q38658279 | Therapeutic targeting in nanomedicine: the future lies in recombinant antibodies |
| Q43964745 | Thrombin-Activatable Microbubbles as Potential Ultrasound Contrast Agents for the Detection of Acute Thrombosis. |
| Q64105469 | Thromboembolic and Bleeding Complications in Transcatheter Aortic Valve Implantation: Insights on Mechanisms, Prophylaxis and Therapy |
| Q90804583 | Ultrasound with Microbubble Contrast Agent and Urokinase for Thrombosis |
| Q58129424 | [Efficacy of combined ultrasound and microbubble treatment for thrombolysis for rescuing ischemic tissues in rats at different time after thrombosis] |
Search more.